Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,349 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $434.19 | 8 | $0 (2019) |
| Stryker Corporation | $216.32 | 1 | $0 (2017) |
| AbbVie Inc. | $177.36 | 9 | $0 (2021) |
| Lilly USA, LLC | $135.57 | 4 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $121.61 | 1 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $111.73 | 1 | $0 (2017) |
| Grifols USA, LLC | $43.43 | 2 | $0 (2020) |
| Allergan Inc. | $37.27 | 2 | $0 (2019) |
| UCB, Inc. | $32.86 | 1 | $0 (2019) |
| Promius Pharma LLC | $20.20 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $177.36 | 9 | AbbVie Inc. ($177.36) |
| 2020 | $265.23 | 5 | Lilly USA, LLC ($123.78) |
| 2019 | $405.00 | 10 | Amgen Inc. ($296.53) |
| 2018 | $173.16 | 5 | Amgen Inc. ($137.66) |
| 2017 | $328.05 | 2 | Stryker Corporation ($216.32) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2020 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Immunology and Neurology | ||||||
| 02/08/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $121.61 | General |
| Category: Central Nervous System | ||||||
| 01/31/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $96.70 | General |
| 01/31/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $19.34 | General |
| 01/31/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $7.74 | General |
| 11/20/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: Neurology | ||||||
| 11/13/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Neuroscience | ||||||
| 08/28/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $110.36 | General |
| Category: Neuroscience | ||||||
| 07/26/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neuroscience | ||||||
| 06/13/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Neuroscience | ||||||
| 05/09/2019 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Immunology and Neurology | ||||||
| 03/20/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Neuroscience | ||||||
| 03/20/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Neuroscience | ||||||
| 02/13/2019 | Promius Pharma LLC | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Neurology | ||||||
| 12/19/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Neuroscience | ||||||
About Dr. Stuart Black, MD
Dr. Stuart Black, MD is a Neurology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679689335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Black, MD has received a total of $1,349 in payments from pharmaceutical and medical device companies, with $177.36 received in 2021. These payments were reported across 31 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,349).
Practice Information
- Specialty Neurology
- Location Dallas, TX
- Active Since 08/22/2006
- Last Updated 12/24/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1679689335
Products in Payments
- Aimovig (Biological) $335.34
- Infinity (Device) $216.32
- UBRELVY (Drug) $177.36
- AJOVY (Biological) $121.61
- APTIOM (Drug) $111.73
- Gamunex-C (Biological) $43.43
- Briviact (Drug) $32.86
- ZEMBRACE SYMTOUCH (Drug) $20.20
- BOTOX (Drug) $20.03
- ZOMIG (Drug) $18.26
- EMGALITY (Drug) $11.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Dallas
Nirav Pavasia, M.d, M.D
Neurology — Payments: $1.3M
Benjamin Greenberg, Md, MD
Neurology — Payments: $691,893
Steven Herzog, M.d, M.D
Neurology — Payments: $519,302
Waleed El-Feky, M.d, M.D
Neurology — Payments: $469,716
Mark Alberts, Md, MD
Neurology — Payments: $417,917
Adnan Subei, D.o, D.O
Neurology — Payments: $274,043